BioCardia resolves Japanese regulatory queries and proceeds with US FDA approval process
BCDA BioCardia Inc
$0.83 -10.38%
View chart & analysis → - 1BioCardia has resolved all remaining questions from Japan's Pharmaceuticals and Medical Devices Agency (PMDA).
- 2BioCardia recorded a net cash usage of $1.7 million from operating activities in the third quarter of 2026.
- 3BioCardia held total cash and cash equivalents of $2.2 million at the end of the quarter.
So what's the key point?
BioCardia has resolved all questions from the Japanese regulatory agency. The company currently holds $2.2 million in cash.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.